AI for Life Sciences


Dana Solutions is a pioneer in the application of AI for in vitro cell-based assays. We offer state-of-the-art AI products for drug screening, toxicity testing, and quality control.

We also partner with companies in medical devices and biotechnology, as well as academia and government institutions, to develop breakthrough products and enable new scientific discoveries.

Products



PHENOLEARN

Artificial Intelligence for
Phenotypic Modeling
and Drug Testing

PhenoLearn lets scientists create and deploy highly accurate and robust models of cellular and tissue phenotypes using artificial intelligence.

Visit PhenoLearn

PULSE

High-Throughout
Contractility Analysis of
Beating Cardiomyocytes

The Pulse web service lets scientists upload their own videos of beating cardiomyocytes for automated analysis of contractility.

Visit Pulse

PHENOTOX

Artificial Intelligence for
In Vitro Structural
Toxicity Testing

PhenoTox uses artificial intelligence to capture drug-induced structural changes in images of cell cultures.

Visit PhenoTox

AUTO-QC

Artificial Intelligence for
Quality Control for
In Vitro Assays

Robust, High-Throughput QC for In Vitro Assays

Visit Auto-QC

Consulting Services


Novel Algorithms

We develop novel algorithms for analyzing biomedical images, videos, and sensor data, tailored to your project requirements.

Product Ready

We develop end-to-end solutions, deployed in your favorite local or cloud-based environment.

Made with Passion

We work as an extended part of your team, and treat every project as if it were one of our own.

Genea Biomedx

Tenaya Therapeutics

Gladstone Institutes

IonPath

Fountain Therapeutics

Stanford Bioengineering

Enspectra Health

Chronus Health

Advanced Reproductive Care ARC

Managing Members


Kevin Loewke, PhD

Mahnaz Maddah, PhD

News & Events



23Sep

Dana Solutions to present and exhibit at SPS 2019 Annual Meeting

Come visit us at booth #702, and see our poster titled "Artificial Intelligence Enables Structural Toxicity Testing for Endpoint and Multiple-Timepoint Assays".


22July

Dana Solutions part of HESI U01 award from the FDA to study cardiac failure modes

Dana Solutions announced today that it will receive a subaward from the Health and Environmental Sciences Institute (HESI) as part of a multi-year U01 grant from the FDA.


27June

Dana Solutions to present at 2019 ISSCR Annual Meeting

Come see our poster T-3222 titled "Artificial Intelligence Captures Structural Toxicity in Human In Vitro Cell Models on Thursday June 27 at 7pm in Poster Session II Even.



Contact Us


3505 El Camino Real
Palo Alto, CA 94306